Active vaccination in patients with common variable immunodeficiency (CVID)

Clinical Immunology

Volumn 124, Issue 3, 2007, Pages 294-303

  Goldacker, S ^a   Draeger, R ^a   Warnatz, K ^a   Huzly, D ^b   Salzer, U ^a   Thiel, J ^a   Eibel, H ^a   Schlesier, M ^a   Peter, H H ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

CVID; IgM memory B cells; Pneumococcal polysaccharides; Polypeptides; Vaccination

Indexed keywords

COMPLEMENT COMPONENT C3D RECEPTOR; CONJUGATE VACCINE; HEPATITIS A HEPATITIS B VACCINE; IMMUNOGLOBULIN G; PEPTIDE ANTIBODY; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; TETANUS TOXOID DIPHTHERIA TOXOID HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE; UNCLASSIFIED DRUG; VACCINE;

ACTIVE IMMUNIZATION; ADULT; AGED; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; MALE; MEMORY CELL; PRIORITY JOURNAL; VACCINATION;

ADULT; AGED; ANTIBODY FORMATION; B-LYMPHOCYTES; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOLOGIC MEMORY; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; PEPTIDES; PNEUMOCOCCAL VACCINES; POLYSACCHARIDES; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 34547849749     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2007.04.011     Document Type: Article

References (40)

1. Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies. Clin. Exp. Immunol. 118 Suppl. 1 (1999) 1-28
2. Chapel H., Geha R., and Rosen F. Primary immunodeficiency diseases: an update. Clin. Exp. Immunol. 132 (2003) 9-15
3. Cunningham-Rundles C., and Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin. Immunol. 92 (1999) 34-48
4. Grimbacher B., Hutloff A., Schlesier M., Glocker E., Warnatz K., Drager R., Eibel H., Fischer B., Schaffer A.A., Mages H.W., Kroczek R.A., and Peter H.H. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat. Immunol. 4 (2003) 261-268
5. Salzer U., Chapel H.M., Webster A.D., Pan-Hammarstrom Q., Schmitt-Graeff A., Schlesier M., Peter H.H., Rockstroh J.K., Schneider P., Schaffer A.A., Hammarstrom L., and Grimbacher B. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat. Genet. 37 (2005) 820-828
6. van Zelm M.C., Reisli I., van der Burg M., Castano D., van Noesel C.J., van Tol M.J., Woellner C., Grimbacher B., Patino P.J., van Dongen J.J., and Franco J.L. An antibody-deficiency syndrome due to mutations in the CD19 gene. N. Engl. J. Med. 354 (2006) 1901-1912
7. Bryant A., Calver N.C., Toubi E., Webster A.D., and Farrant J. Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2. Clin. Immunol. Immunopathol. 56 (1990) 239-248
8. Warnatz K., Denz A., Drager R., Braun M., Groth C., Wolff-Vorbeck G., Eibel H., Schlesier M., and Peter H.H. Severe deficiency of switched memory B cells (CD27(+)IgM(-) IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 99 (2002) 1544-1551
9. Piqueras B., Lavenu-Bombled C., Galicier L., Bergeron-van der Cruyssen F., Mouthon L., Chevret S., Debre P., Schmitt C., and Oksenhendler E. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J. Clin. Immunol. 23 (2003) 385-400
10. Hermans P.E., Diaz-Buxo J.A., and Stobo J.D. Idiopathic late-onset immunoglobulin deficiency. Clinical observations in 50 patients. Am. J. Med. 61 (1976) 221-237
11. Rodrigo M.J., Vendrell M., Cruz M.J., Miravitlles M., Pascual C., Morell F., and De Gracia J. Utility of the antibody response to a conjugated Haemophilus influenzae type B vaccine for diagnosis of primary humoral immunodeficiency. Am. J. Respir. Crit Care Med. 162 (2000) 1462-1465
12. Spickett G.P. Current perspectives on common variable immunodeficiency (CVID). Clin. Exp. Allergy 31 (2001) 536-542
13. De Gracia J., Vendrell M., Alvarez A., Pallisa E., Rodrigo M.J., de la R.D., Mata F., Andreu J., and Morell F. Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency. Int. Immunopharmacol. 4 (2004) 745-753
14. Ko J., Radigan L., and Cunningham-Rundles C. Immune competence and switched memory B cells in common variable immunodeficiency. Clin. Immunol. 116 (2005) 37-41
15. Al Herz W., and McGeady S.J. Antibody response in common variable immunodeficiency. Ann. Allergy, Asthma, Immunol. 90 (2003) 244-247
16. Cunningham-Rundles C., Bodian C., Ochs H.D., Martin S., Reiter-Wong M., and Zhuo Z. Long-term low-dose IL-2 enhances immune function in common variable immunodeficiency. Clin. Immunol. 100 (2001) 181-190
17. Moratto D., Gulino A.V., Fontana S., Mori L., Pirovano S., Soresina A., Meini A., Imberti L., Notarangelo L.D., Plebani A., and Badolato R. Combined decrease of defined B and T cell subsets in a group of common variable immunodeficiency patients. Clin. Immunol. 121 (2006) 203-214
18. Kruetzmann S., Rosado M.M., Weber H., Germing U., Tournilhac O., Peter H.H., Berner R., Peters A., Boehm T., Plebani A., Quinti I., and Carsetti R. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J. Exp. Med. 197 (2003) 939-945
19. Weller S., Braun M.C., Tan B.K., Rosenwald A., Cordier C., Conley M.E., Plebani A., Kumararatne D.S., Bonnet D., Tournilhac O., Tchernia G., Steiniger B., Staudt L.M., Casanova J.L., Reynaud C.A., and Weill J.C. Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 104 (2004) 3647-3654
20. Rump J.A., Jahreis A., Schlesier M., Dräger R., Melchers I., and Peter H.H. Possible role of IL-2 deficiency for hypogammaglobulinaemia in patients with common variable immunodeficiency. Clin. Exp. Immunol. 89 (1992) 204-210
21. STIKO. Empfehlungen der staendigen Impfkommission am Robert-Koch-Institut. Epidemiol. Bull. 28 (2002) 227-242
22. Quataert S.A., Kirch C.S., Wiedl L.J., Phipps D.C., Strohmeyer S., Cimino C.O., Skuse J., and Madore D.V. Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S. Clin. Diagn. Lab. Immunol. 2 (1995) 590-597
23. Chalmers A., Scheifele D., Patterson C., Williams D., Weber J., Shuckett R., and Teufel A. Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity. J. Rheumatol. 21 (1994) 1203-1206
24. Go E.S., and Ballas Z.K. Anti-pneumococcal antibody response in normal subjects: a meta-analysis. J. Allergy Clin. Immunol. 98 (1996) 205-215
25. Sorensen R.U., Leiva L.E., Javier III F.C., Sacerdote D.M., Bradford N., Butler B., Giangrosso P.A., and Moore C. Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations. J. Allergy Clin. Immunol. 102 (1998) 215-221
26. Robert-Koch-Institut. Zur Impfung gegen Pneumokokken-Infektionen. Epidemiol. Bull. 12 (2000) 97-99
27. STIKO. Hinweise zu Impfungen für Patienten mit Immundefizienz. Epidemiol. Bull. 39 (2005) 353-364
28. van Kessel D.A., Velzen-Blad H., van den Bosch J.M., and Rijkers G.T. Impaired pneumococcal antibody response in bronchiectasis of unknown aetiology. Eur. Respir. J. 25 (2005) 482-489
29. Carsetti R., Rosado M.M., Donnanno S., Guazzi V., Soresina A., Meini A., Plebani A., Aiuti F., and Quinti I. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J. Allergy Clin. Immunol. 115 (2005) 412-417
30. Concepcion N.F., and Frasch C.E. Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay. Clin. Diagn. Lab. Immunol. 8 (2001) 266-272
31. WHO Expert Committee on Biological Standardization. W.H.O. Tech. Rep. Ser. 927 (2005) 1-154
32. Carsetti R., Rosado M.M., and Wardmann H. Peripheral development of B cells in mouse and man. Immunol. Rev. 197 (2004) 179-191
33. Rosen H., and Goetzl E.J. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat. Rev., Immunol. 5 (2005) 560-570
34. Tafuri A., Shahinian A., Bladt F., Yoshinaga S.K., Jordana M., Wakeham A., Boucher L.M., Bouchard D., Chan V.S., Duncan G., Odermatt B., Ho A., Itie A., Horan T., Whoriskey J.S., Pawson T., Penninger J.M., Ohashi P.S., and Mak T.W. ICOS is essential for effective T-helper-cell responses. Nature 409 (2001) 105-109
35. Warnatz K., Bossaller L., Salzer U., Skrabl-Baumgartner A., Schwinger W., van der Burg M., van Dongen J.J., Orlowska-Volk M., Knoth R., Durandy A., Draeger R., Schlesier M., Peter H.H., and Grimbacher B. Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency. Blood 107 (2006) 3045-3052
36. Shilling R.A., Bandukwala H.S., and Sperling A.I. Regulation of T:B cell interactions by the inducible costimulator molecule: does ICOS "induce" disease?. Clin. Immunol. 121 (2006) 13-18
37. Jeurissen A., Wuyts G., Kasran A., Ramdien-Murli S., Blanckaert N., Boon L., Ceuppens J.L., and Bossuyt X. The human antibody response to pneumococcal capsular polysaccharides is dependent on the CD40-CD40 ligand interaction. Eur. J. Immunol. 34 (2004) 850-858
38. Herbst E.W., Armbruster M., Rump J.A., Buscher H.-P., and Peter H.H. Intestinal B cell defects in common variable immunodeficiency. Clin. Exp. Immunol. 95 (1994) 215-221
39. Mackay F., and Ambrose C. The TNF family members BAFF and APRIL: the growing complexity. Cytokine Growth Factor Rev. 14 (2003) 311-324
40. Castigli E., Wilson S.A., Scott S., Dedeoglu F., Xu S., Lam K.P., Bram R.J., Jabara H., and Geha R.S. TACI and BAFF-R mediate isotype switching in B cells. J. Exp. Med. 201 (2005) 35-39